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Abstract
The innovative performance of companies has been studied quite extensively and for a long period of time. However, the
results of many studies have not yet led to a generally accepted indicator of innovative performance or a common set of
indicators. So far the variety in terms of constructs, measurements, samples, industries and countries has been substantial.
This paper studies the innovative performance of a large international sample of nearly 1200 companies in four high-tech
industries, using a variety of indicators. These indicators range from R&D inputs, patent counts and patent citations to new
product announcements. The study establishes that a composite construct based on these four indicators clearly catches a latent
variable ‘innovative performance’. However, our findings also suggest that the statistical overlap between these indicators is
that strong that future research might also consider using any of these indicators to measure the innovative performance of
companies in high-tech industries.
© 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
The management and applied economics literature
on innovation and related topics has a long history
of struggling with the measurement of the innova-
tive performance of companies. Both generally avail-
able measures such as R&D inputs, patent counts,
patent citations, or counts of new product announce-
ments, and more specific survey-based measurements
of this particular performance by companies have been
used in trying to capture this innovative performance
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of companies.1 Many studies use a single indicator
(R&D, patents, patent citations, or new product an-
nouncements) arguing that the specific indicator that
is applied has fewer shortcomings than the other in-
dicators. Some studies use two or more indicators
to generate one construct. Given the variety in con-
structs, measurements, samples, databases, industries
and country settings and inconsistency in definitions,
1 In the following, we will mainly consider these generally avail-
able innovation measures found in the public domain or in large
databases and not those obtained from survey-research. Biblio-
metric indicators could also be used for measuring research out-
put in terms of the yield of scientific papers. However, there are
some serious methodological problems in relating classifications
of fields of scientific output to technology and industry classi-
fications. Moreover, this paper focuses on the measurement of
innovative performance and not on scientific performance.
0048-7333/$ – see front matter © 2002 Elsevier Science B.V. All rights reserved.
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it is of no surprise that there appears to be hardly any
clear understanding of the concept and measurement
of innovative performance.
The main purpose of this paper is to establish a
better understanding of the innovative performance
of companies, considering the possible use of both a
number of single indicators or various combinations
of multiple indicators in a composite measure of per-
formance. This exercise implies that we attempt to
measure ‘the’ quality of performance by means of a
latent variable and that we analyse the usefulness of
multiple indicators, constructing a composite measure
of the innovative performance of companies (see also
Lanjouw and Schankerman, 1999). The advantage of
such a multi-indicator approach is that, instead of as-
suming the ‘correctness’ of a single indicator, proba-
bly taken for reasons of convenience, an analysis of
multiple indicators might allow us to measure innova-
tive performance through a more complex, more in-
formative, composite measure. In addition to this, a
composite measure can be analysed in detail, in terms
of the individual indicators and with reference to the
contribution of each indicator to the latent variable ‘in-
novative performance’. This particular approach en-
ables us to measure the information gains from using
particular indicators. This latter aspect of the analysis
also indicates that our research does not imply that a
multiple-indicator approach is by definition superior.
In case of strong statistical association between indi-
cators, each indicator could replace any other measure
used in the analysis.
Given the purpose of this paper, it should be clear
that this paper is methodological in nature as it
presents an analysis of the measurement of innovative
performance. It does not outline a theory or a model
analysing and explaining differences in the innovative
performance of companies. In that sense, the following
analysis is self-referential, i.e. innovative performance
is exclusively defined in terms of individual measures
or the common factor linking the different indicators
used in the analysis. The main objective of this paper,
therefore, is to better understand the possible advan-
tages of specific single indicators or of composite
measures, using multiple indicators related to latent
variables, that conditional on the observed characteris-
tics of these indicators, might generate greater insight.
In the following, we will first discuss a number of
concepts that are relevant in the context of measur-
ing innovative performance and that also enable us to
picture the possible relationships between the differ-
ent indicators of this performance. The next section
presents an overview of the literature on indicators
such as R&D input, patent counts, patent citations and
new product announcements. In that context it turns
out that R&D inputs could be a reasonable indicator
of innovative effort, patents could be a more than ac-
ceptable indicator of innovative output, patent citations
could be used to measure the quality of innovative
output and new product announcements could indicate
the level of product innovation. We will also discuss
the possible statistical relationship between these in-
dicators as found in a number of studies. Based on
our understanding of previous research, we will for-
mulate three research questions. This is followed by a
description of the large international sample of compa-
nies in four high-tech sectors and a description of the
specific variables that we will analyse. We also offer
a brief explanation of the rationale behind the choice
of industries. The four high-tech studies for which we
will investigate the appropriate measures of innovative
performance are aerospace and defense, computer and
office machinery, pharmaceuticals and electronics and
communications. The empirical analysis of the dif-
ferent indicators of innovative performance, based on
factor analysis, will be presented in the next section.
This is followed by a discussion of the results and the
conclusions that can be drawn from this study.
2. The relationship between inventive,
technological and innovative performance
Concepts such as invention, technology and innova-
tion and the related performance of companies have to
be clearly defined in order to improve our comprehen-
sion of some technical issues related to the measure-
ment of innovation. Therefore, we will briefly outline
our understanding of each of these concepts.
We define inventive performance as the achieve-
ments of companies in terms of ideas, sketches,
models of new devices, products, processes and sys-
tems (Ernst, 2001; Freeman and Soete, 1997). As
discussed further below, inventive performance is fre-
quently measured in the context of patents where both
raw counts of patents and patent citations are taken
as the actual measures. Following Griliches (1998),
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Fig. 1. Venn diagrams representing the relationship between R&D, patents and new products in two hypothetical industries or two
industry-average companies (A and B) with different degrees of overlap (see also Basberg, 1987).
technological performance can be defined as the ac-
complishment of companies with regard to the com-
bination of their R&D input, as an indicator of their
research capabilities, and their R&D output in terms
of patents. We can also differentiate between innova-
tive performance in the narrow and in the broad sense.
Innovative performance in the narrow sense refers to
results for companies in terms of the degree to which
they actually introduce inventions into the market,
i.e. their rate of introduction of new products, new
process systems or new devices (Freeman and Soete,
1997). In that case new product announcements can
be applied as an indicator of innovative performance.
A broader understanding of innovative performance
encompasses the three previous measures of perfor-
mance as it indicates the achievement in the trajectory
from conception of an idea up to the introduction of
an invention into the market (Ernst, 2001). This broad
innovative performance therefore overarches the mea-
surement of all stages from R&D to patenting and
new product introduction. In other words, this defi-
nition of innovative performance in the broad sense
focuses on both the technical aspects of innovation
and the introduction of new products into the market,
but it excludes the possible economic success of in-
novations as such (see also Acs and Audretsch, 1989;
Ahuja and Katila, 2001; Archibugi, 1992; Ernst, 2001;
Freeman and Soete, 1997; Grupp, 1994; Lanjouw and
Schankerman, 1999; Stuart, 2000; Trajtenberg, 1990).
Our understanding of the different measures, which
might interact in the innovative performance of com-
panies, can be explained further using Venn diagrams.
These Venn diagrams picture the possible overlap be-
tween R&D, patents (both counts and citations) and
new product announcements as indicators of innova-
tive performance, see Fig. 1. It is well known that the
overlap between R&D, patents and new products is not
necessarily complete. Full (100%) overlap is usually
not expected because not all patents are directly re-
lated to R&D and the same applies to new products of
which only a part of the total number are protected by
patents. Also, the space in the squares that surround the
Venn diagrams can represent non-measurable techno-
logical change or technological change not accounted
for by these measures.
The actual intersection between R&D, patents and
new products in the Venn diagrams depend on the
specific nature of the industry. We submit that the
degree of overlap between R&D, patents and new
product announcements determines the usefulness of
single or multiple indicators. The more an industry or
its average company is characterized by a high R&D
intensity, high patenting intensity and a high ratio for
new product introduction, the larger the intersection
in the Venn diagram. In case the overlap is complete
or almost complete, i.e. in case of (nearly) complete
association of measures, the assessment of innova-
tive performance can probably be limited to one of
the overlapping indicators (see Fig. 1B). In case the
overlap is very small, one has to clearly differentiate
between inventive performance, technological perfor-
mance and innovative performance in the narrow sense
(see Fig. 1A). In other cases with varying degrees of
overlap between R&D, patents and new products, the
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use of multiple indicators might provide a better un-
derstanding of the actual innovative performance of
companies.
3. Indicators of innovative performance
As discussed briefly in the above, we can analyse
technological performance, inventive performance,
and innovative performance in the narrow sense in
terms of R&D inputs, patent counts, patent cita-
tions, and new product announcements. These in-
dicators can be used individually or combined in
a multi-dimensional setting to measure innovative
performance in the broader sense.
The current literature on the measurement of in-
novation points towards some interesting perspectives
on using these different indicators. In the following,
we will present a brief overview of this literature that
will be helpful in providing some background to our
research questions.
3.1. R&D inputs
The literature usually takes R&D expenditures
primarily as an input indicator of the efforts that
companies make in establishing R&D that might
eventually lead to output. However, apart from the
actual correlation of R&D input with R&D output
through patents (Griliches, 1990, 1998; Hausman
et al., 1984; Hitt et al., 1997), R&D efforts can also
indicate the innovative competences of companies
that are found to affect the performance of compa-
nies, particularly in high-tech industries (Duysters and
Hagedoorn, 2001; Henderson and Cockburn, 1994).
In that context, R&D inputs of companies are part of
the broader routines that companies follow in their
innovative efforts, where previous R&D expenditures
affect subsequent R&D inputs (Nelson and Winter,
1982). Successful R&D input at a previous stage will
increase the commitment to the allocation of future
R&D resources. In other words, within the routines
that most companies have developed in managing
their R&D inputs, the actual R&D efforts not only
reflect current input but also their previous successes
that are an integral part of the skills that companies
develop in creating an R&D strategy with a stable set
of long-term projects (Hagedoorn, 1989). We expect
that, particularly in high-tech industries, R&D inputs
are as much affecting future output as they are part of
the current technological performance of a company
in terms of generating new ideas, new blue prints and
new models, part of which will eventually lead to new
patents and new products (Griliches, 1998; Baysinger
and Hoskisson, 1989; Hall, 1990).
3.2. Patents
As most of the other indicators, the patent measure,
in particular the use of raw patent counts, is subject
to a longstanding debate regarding its bias and short-
comings (Archibugi, 1992; Cohen and Levin, 1989;
Dosi, 1988; Griliches, 1998). International and sec-
toral differences in patenting behaviour, differences
in patenting between large companies and smaller
firms, the identical weight given to some very im-
portant patents as well as to run-of-the-mill patents,
the fact that patents only cover a part of the over-
all trajectory from R&D to innovation, all of these
‘shortcomings’ feature in the literature that discusses
the use of patents.
However, it appears that, certainly in large parts of
the economics literature, raw patent counts are gener-
ally accepted as one of the most appropriate indica-
tors that enable researchers to compare the inventive
or innovative performance of companies in terms of
new technologies, new processes and new products
(Acs and Audretsch, 1989; Aspden, 1983; Bresman
et al., 1999; Cantwell and Hodson, 1991; Freeman
and Soete, 1997; Griliches, 1998; Napolitano and
Sirilli, 1990; Patel and Pavitt, 1995; Pavitt, 1988).
Even authors who are somewhat critical of the overall
use of patents as a performance indicator, such as
Arundel and Kabla (1998) and Mansfield (1986), ad-
mit that patents can be an appropriate indicator in the
context of many high-tech sectors. These literatures
also suggest that the less patents are used for broad
cross-sectional analysis that ignores inter-sectoral dif-
ferences in the propensity to patent, the better patents
reflect the performance of companies in one or a few
sectors (see also Ernst, 2001).
3.3. Patent citations
Increasingly researchers are using patent citations
as an indicator of inventive performance of companies.
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Compared to raw counts of patents, which generate a
purely quantitative measure, patent citations also in-
clude a measure of the quality of patents. The ba-
sic assumption in using this indicator is that there is
a positive relationship between the importance of a
patent and the degree to which a patent is cited in later
patents. This information on previous patents can be
traced in each patent application as it is required that
each patent cites earlier patents with somewhat simi-
lar or related technical claims, also known as the rel-
evant prior art. The number of patent citations for a
particular patent indicates its importance or impact.
Patent specialists are somewhat sceptical about the
counting of patent citations without the necessary
in-depth knowledge necessary to interpret the un-
derlying citation reports that accompany each patent
(Michel and Bettels, 2001). However, quantitative
analysis of large numbers of patents and patent ci-
tations is frequently used in economics (for instance
Harhoff et al., 1999; Jaffe et al., 1993; Trajtenberg,
1990) and the management literature (for instance
Rosenkopf and Nerkar, 2001; Stuart, 2000).
Evidence of the validity of patent citations as an
indicator of the quality of inventions or innovations, in
terms of the correlation between the inter-subjective
assessment of the importance of patents by technical
specialists and the number of citations, is found in a
number of studies (Albert et al., 1991; Carpenter et al.,
1981; Karki, 1997; Narin et al., 1987; Pavitt, 1988).
3.4. New product announcements
Some contributions use new product announce-
ments, traced through various sources and databases,
as an indicator of the innovative performance of com-
panies. In their study on 250 US companies, Hitt
et al. (1996) apply the degree to which new product
announcements of companies were found in Dialog’s
NPA/plus database as a part of a combined indicator
of the innovativeness of companies. Devinney (1993)
shows that the positive relationship between the num-
ber of patents and new product announcements is
primarily found at the level of industries and not at
the level of individual companies, where less than
3% of the variance in individual firm new product
announcements is explained by patent intensity.
One of the main problems with using new prod-
uct announcements, as for instance found in various
databases, is that these announcements are based on
the press releases of the marketing departments of
companies and little or no screening appears to be
undertaken by the database operators themselves. In
other words, new product announcements by compa-
nies themselves are simply accepted as long as compa-
nies identify them as such. Patents, on the other hand,
in particular those registered in an advanced economy
such as the USA, are screened for their original contri-
bution both during the pre-application period and dur-
ing the actual application period by in-company en-
gineers, patent lawyers and by patent office officials.
Therefore, more than with some of the other indica-
tors, careful screening of the data might be necessary
with new product announcements in order to avoid
major problems with the validity of the results.
3.5. The statistical association of R&D, patents
and new product announcement
As so many studies apply different indicators, it ap-
pears interesting to get a better understanding of the
likely statistical association between these different in-
dicators. The majority of studies use only one single
indicator but a number of studies use multiple indica-
tors or report on the correlation between some of the
indicators mentioned in the above. However, the lit-
erature reporting more than one indicator appears to
present a somewhat diverse picture when it comes to
the possible relationship between R&D inputs, patent
counts and citations, and new products.
Seminal studies by Pakes and Griliches (1984) and
Bound et al. (1984) find a rather strong relationship
between R&D and the number of patents across firms
and industries. Ahuja and Katila’s (2001) study of the
international chemical industry reports a correlation of
nearly 0.9 between R&D inputs and patent counts. In
their analysis of the international computer industry,
Hagedoorn and Duysters (2002) mention a correlation
of over 0.5 between the R&D intensity of companies
and their patent counts. However, in their study of US
companies involved in nearly 200 acquisitions, Hitt
et al. (1991) show a low correlation of only about 0.2
between the R&D intensity of these companies and
their patent intensity.
In one of their early small-scale studies, Narin et al.
(1987) find that the quality of research inputs of com-
panies is highly correlated with raw patent counts and
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patent citations. Trajtenberg (1990) demonstrates that
citation-weighted patent numbers of companies are
more closely correlated with their output measures
of innovation, whereas unweighted patent counts are
more closely related to R&D expenditures of compa-
nies. Stuart (2000) reports a very high correlation of
over 0.8 between raw patent counts and patent cita-
tions, the actual measure of innovation in a sample
of 150 semiconductor firms. However, Rosenkopf and
Nerkar (2001), who studied a smaller sample of optical
disk manufacturing companies, find a relatively low
correlation of about 0.3 between number of patents
and patent citation indicators.
In a study of a sample of 250 US companies, Hitt
et al. (1996) establish a substantial correlation of 0.5
between the R&D intensity of companies and their
new product intensity, i.e. the number of new prod-
uct announcements controlled for size of companies.
Brouwer and Kleinknecht (1999) indicate some corre-
lation between patenting and sales of innovative prod-
ucts, although this correlation is far from perfect. As
already indicated in the above, Devinney (1993) shows
that the specific relationship between the patenting of
companies and their new product announcements turns
out to be quite weak.
4. Research questions
It is obvious from the above that the literature
generates a rather mixed bag of findings, to say the
least. Some studies suggest that, given the rather high
correlation between some indicators, any of these cor-
related measures could be used as a partial or overall
indicator of performance. Yet, the lack of any statisti-
cal association found for the same indicators in other
studies, appears to suggest that the results from stud-
ies using any of these particular measures could be
indicator-driven. However, the level of intermediate
statistical association between a number of measures,
as found in yet another set of studies, indicates that
one composite construct with various measures could
capture a latent variable that expresses the degree
of innovative performance in the broader sense. The
somewhat unclear nature of the measurement of in-
novative performance and other performance indica-
tors, as found in large parts of the literature, appears
influenced by a lack of systematic research in multi-
ple industries, while frequently using only relatively
small samples of companies in a domestic context.
Our understanding of the literature, as outlined in
the above, suggests a number of research questions. In
order to overcome the major shortcomings of previ-
ous research, we will investigate these questions em-
pirically in an international, large-scale, multi-sectoral
setting. These research questions are:
1. Is there a systematic disparity between different in-
dicators such as R&D inputs, patent counts, patent
citations and new product announcements?
2. Is there a statistical communality between two or
more indicators, indicating that a composite con-
struct could capture a latent variable?
3. Is the statistical association between two or more
indicators of such a nature that each of these indi-
cators can be applied as a representative indicator
of innovative performance?
5. Research methodology
5.1. Sample
Our large, international sample of companies cov-
ers four high-tech industries: aerospace and defense
(SIC-codes 372 and 376), computer and office ma-
chinery (SIC-code 357), pharmaceuticals (SIC-code
283) and electronics and communications (SIC-code
36). These high-tech sectors are selected because it is
known that particularly in these industries R&D ex-
penditures, patents and new products play a role in in-
dicating important aspects of innovative performance
(OECD, 1997). Our sample consists of 1194 com-
panies of which 51.17% is found in the electronics
and communications industry, 23.45% is in computer
and office machinery, 20.44% is in pharmaceuticals,
and 4.94% belongs to the aerospace and defense
sector.
The literature (Brouwer and Kleinknecht, 1999;
Devinney, 1993; Ernst, 2001; Griliches, 1998) sug-
gests that sectoral differences can play a role in ex-
plaining the various outcomes with respect to different
indicators of innovative performance. Therefore, we
will present the results of our analysis for the sample
of companies as a whole as well as for each of the
sub-samples for the different industries. As suggested
by Ernst (2001), we also differentiate internationally
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Table 1
Distribution of size classes of companies in the total sample and for industry sub-samples (1998 annual revenues in US$ millions)
Size classes Total Aerospace and
defense
Computers and
office machinery
Pharmaceuticals Electronics and
communications
0 < 100 (%) 66.67 61.01 69.64 70.49 64.32
100 < 1000 (%) 18.59 16.94 17.14 13.94 21.28
>1000 (%) 14.74 22.05 13.22 15.57 14.40
Total (%) 100 100 100 100 100
N 1194 59 280 244 611
between a North American sub-sample (70.02%) and
companies from other countries, mainly in Europe
and Asia (29.98%). Some details regarding the sec-
toral and international breakdown of this sample are
presented in Appendix A.
Our sample is also diverse in terms of the distri-
bution of the size of companies, representing many
size-categories of innovating firms (see Table 1). Most
of the companies in our sample (61.39%) are rela-
tively small with annual revenues of up to a maximum
of US$ 100 millions. A substantial number of com-
panies (14.74%) can be characterized as very large
with annual revenues of over US$ 1 billion. Nearly
one quarter of the sample (18.59%) can be found in
an intermediate size-class. Obviously, there are differ-
ences between the industry sub-samples but for each
sector we do find a diverse picture in terms of the
size-categories for companies.
It is well known that there is no ‘official’ database
with a world-wide, industry-level list of all compa-
nies from which one can draw a random sample. Our
sample is taken from the Securities Data databank on
international companies, which provides information
on companies in various industries, including those
that were selected for this study. We concentrated on
manufacturing sectors because some of the indicators
more effectively capture aspects of technical innova-
tion rather than of service innovation (Kleinknecht,
1999). Additional information on revenues and R&D
expenditures of companies in this sample was identi-
fied through various other datasets such as Amadeus,
Compustat, the Fortune 500 list, and Worldscope.
Companies entered the sample if the value of at least
one of the variables used in the analysis had a value
higher than zero. In other words, companies with zero
R&D, zero patents, zero patent citations and zero new
products were excluded.
5.2. Variables and data sources
R&D expenditures of companies are measured
annually and standardized by converting the finan-
cial data from national currencies to US dollars.
Data on R&D expenditures were obtained through
the well-known databases mentioned in the previous
section and through additional internet searches.
We utilize the yearly number of all patents granted
to each company as a second indicator. The data on
patents are taken from the US Patent and Trademark
Office (USPTO) database. We use US patent data for
both US and non-US firms. Although these US data
could imply a bias in favour of US companies against
non-US firms, it is mentioned in the literature that
given the importance of the US market, the ‘real’
patent protection offered by US authorities, and the
level of technological sophistication of the US market,
it is often compulsory for non-US companies to file
patents in the USA (Patel and Pavitt, 1991). Further-
more, to maintain a certain level of consistency, relia-
bility and comparability it is necessary to choose one
patenting system instead of several patenting systems
across nations (Ahuja and Katila, 2001).2
Patent citations for each firm are counted as the
yearly patent citations of their patents in all patent
classes. Data on patent citations are also taken from
the USPTO database.
New products or new product announcements are
counted annually for each company in sectors such
as aerospace and defense, computers, office equip-
ment, pharmaceuticals, semiconductors and telecom,
2 With hindsight it turned out that there is little indication
of major differences between North American (largely US) and
non-North American companies, see the correlation for patents
and other measures in Appendix B.
1372 J. Hagedoorn, M. Cloodt / Research Policy 32 (2003) 1365–1379
as found in the RDS Business & Industry databank
owned by the Gale Group. This database contains
the full text of press releases from all industries
covering announcements related to products, with
a focus on new products and services. In addition
to product descriptions, the press releases generally
contain key details about new products and technolo-
gies, including technical specifications, availability,
uses, licensing agreements, distribution channels, and
prices. The database covers more than 1500 techni-
cal and non-technical journals and can be found on
http://www.gale.com. For this study, we separated
announcements of product development projects and
new services from new product introduction and only
use the latter information in the analysis.
For annual R&D expenditures and yearly patent
counts data are obtained for the period 1992–1999,
annual patent citations are registered for the years
1992–1998, and yearly new product announcements
are counted for the period 1997–2000. We measured
the performance of companies in the sample as a
whole and for each sub-sample on each indicator with
alternating time periods. The first period covers the
years 1997 and 1998 for all indicators without any
time lags between various indicators. All indicators
in the data set share the years 1997 and 1998. The
second time period (1995–1999) has an average lag
of 1 year between indicators and the third time period
(1992–1999) has an average lag of 2 years between
indicators. The fourth period is based on different time
lags as mentioned in the literature (Cincera, 1997; Hall
et al., 1986, 2000; Kondo, 1999; Napolitano and
Sirilli, 1990; Pakes, 1985; Pakes and Griliches, 1984;
Scherer, 1984a,b). For this period, we took lags of
3 years between R&D and patents granted, 2 years
between patents granted and patent citations, and 1
year between patent citations and new products.
6. Results
Our research questions suggest that we are basically
making an attempt to understand innovative perfor-
mance in terms of the possible causal structure among
a number of indicators (variables), considering a set of
common underlying dimensions or factors. Therefore,
factor analysis is applied to examine our research ques-
tions. The results of this analysis will only be reported
Table 2
Means and standard deviations for the sample as a whole and
sub-samples
Variables Mean Standard deviation
Total
R&D expenditures 216016.4 619104.549
Patent counts 46.702 181.554
Patent citations 231.519 1007.653
New products 13.399 49.276
Aerospace and defense
R&D expenditures 178162.8 417559.314
Patent counts 11.063 28.36
Patent citations 44.688 111.589
New products 2.125 4.839
Computers and office machinery
R&D expenditures 195251.1 606422.472
Patent counts 63.847 251.625
Patent citations 343.435 1482.674
New products 24.528 76.719
Pharmaceuticals
R&D expenditures 291918.6 560573.466
Patent counts 25.187 54.803
Patent citations 74.869 177.736
New products 7.657 14.792
Electronics and communications
R&D expenditures 198493.6 662087.785
Patent counts 51.255 186.088
Patent citations 263.267 989.636
New products 11.942 44.501
Note: R&D expenditures are in thousands of US$.
for the overall sample and its sub-samples for the pe-
riod 1997–1998. The results for the analyses with dif-
ferent time lags turned out to be almost identical with
no significant differences. Some descriptive data on
the means and standard deviations for the overall sam-
ple and sub-samples are presented in Table 2. Some
additional descriptive data on the relationship between
indicators for the overall sample and the sub-samples
are given in Appendix F. These data suggest that there
are inter-sectoral differences between the ratios for the
different indicators. In that sense, despite the fact that
all four sectors are high-tech industries, there are dif-
ferences with regard to the degree to which, for in-
stance particular levels of R&D lead to patents and
new products. This phenomenon stresses the impor-
tance of understanding inter-sectoral differences, it
does not question the use of this particular group of
indicators. In order to discover the usefulness of these
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Table 3
Correlations
Variables Total Aerospace and
defense
Computers and
office machinery
Pharmaceuticals Electronics and
communications
Patents and patent citations 0.941 0.805 0.973 0.777 0.925
Patents and R&D expenditures 0.783 0.874 0.931 0.704 0.812
Patents and new products 0.798 0.475 0.793 0.589 0.830
Patent citations and R&D expenditures 0.709 0.856 0.891 0.704 0.748
Patent citations and new products 0.808 0.741 0.789 0.382 0.851
R&D expenditures and new products 0.734 0.666 0.907 0.817 0.763
different indicators, we will first have to consider the
outcomes of the factor analysis, presented below.
Obviously a factor model can only be appropriate
if variables are to some extent related to each other.3
If correlations between variables are lower than 0.30,
it is unlikely that they share common factors. In our
sample and sub-samples correlations are greater than
0.30, suggesting that a factor analysis is appropriate
(see Table 3). Similar correlations are found for the
sub-samples for North American companies and other
companies (see Appendix B). An exception is found
for the aerospace and defense industry in non-North
American countries. The irregular pattern of correla-
tions, found for this industry and these countries, is
probably caused by the relatively small number of 21
companies.4
A somewhat more advanced method of determining
the appropriateness of factor analysis is the Kaiser–
Meyer–Olkin (KMO) measure. The KMO measure is
an index for comparing the magnitudes of the observed
correlation coefficients to the magnitudes of the partial
3 Some of the variables (i.e. patent counts and patent citations)
could be too strongly dependent on each other if a large number
of companies have only zero patents which, ignoring time, will by
definition lead to zero patent citations. This will have an upward
effect on the correlations. However, within a given period of time
(e.g. 1997–1998) or even in each of the other lagged periods, patent
citations do not necessarily refer to the patent counts from the
same or lagged periods. Furthermore, 47.65% of the companies in
the sample do not have patents whereas 38.11% of the companies
have no patent citations. Or to put it differently, 36.38% of the
companies in this sample that do not have patents in any of these
periods, still have patent citations.
4 As noted in the literature (Hair et al., 1995) factor analyti-
cal methods are not well suited in case of a small sample and
a low ratio of observations to variables. Even seemingly mean-
ingful results, obtained from such samples, should be interpreted
cautiously.
correlation coefficients (Norusis, 1993). Higher values
for this measure indicate the degree of appropriateness
of using factor analysis. In addition to this we can also
calculate a measure of sampling adequacy (MSA) for
each individual variable. Again, values for this mea-
sure indicate whether factor analysis is appropriate or
not. For our sample, both the KMO and the MSA
measures indicate that factor analysis is an appropri-
ate method to test if R&D expenditures, patent counts,
patent citation counts, and new products share one or
more common factors (see Appendix C). This implies
that we can continue with the second stage of the statis-
tical analysis, i.e. exploratory factor analysis by means
of principal component analysis (Hair et al., 1995).
The results of the initial unrotated factor analysis are
very straightforward as the analysis generates only one
factor. Given this one-factor solution there is no further
need for rotation of factors. The results of the initial
unrotated factor analysis are presented in Tables 4 and
5 and Appendices D and E. Table 4, labelled commu-
nality measures, is an indication of the strength of the
linear association among variables. Squaring the cor-
relation coefficient shows the amount of the variable’s
total variance accounted for by the factor (Norusis,
1993). Small squared multiple correlation coefficients
suggest that the variable should be eliminated from
the analysis.
Over 75% of the communalities are greater than
0.80, suggesting that 80% or more of the variable’s
total variance is accounted for by the factor. In gen-
eral there are not many differences between the com-
munalities calculated for the sample as a whole and
the industry sub-samples (see Table 4). The relatively
largest differences involve the variables R&D expen-
ditures and new products. The variable R&D expen-
ditures has somewhat lower communalities for the
sample as a whole, for the pharmaceutical industry and
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Table 4
Communality measures
Variables Total Aerospace and
defense
Computers and
office machinery
Pharmaceuticals Electronics and
communications
R&D expenditures 0.761 0.906 0.955 0.802 0.791
Patent counts 0.920 0.787 0.941 0.819 0.921
Patent citations 0.888 0.905 0.918 0.600 0.900
New products 0.822 0.627 0.831 0.676 0.856
Table 5
Results of the initial unrotated factor analysis for component 1
Variables Total Aerospace and
defense
Computers and
office machinery
Pharmaceuticals Electronics and
communications
R&D expenditures 0.872 0.952 0.977 0.896 0.889
Patent counts 0.959 0.887 0.970 0.905 0.960
Patent citations 0.943 0.951 0.958 0.774 0.949
New products 0.907 0.792 0.912 0.822 0.925
Total Eigenvalue 3.391 3.224 3.644 2.897 3.467
% variance explained 84.77 80.60 91.10 72.43 86.69
for the electronics and communications industry. The
variable new products has lower communalities for the
aerospace and defense industry and for the pharma-
ceuticals industry. An interesting finding is that, com-
pared with the other industries, the communalities for
the pharmaceutical industry show relatively low val-
ues. As indicated by Appendix D the results for com-
panies from North America and for those from other
countries are not significantly different.
Table 5 and Appendix E present the results of the
factor analysis. Each row in the table and the ap-
pendix contains a factor loading indicating the cor-
relation of that specific variable and the factor. High
loadings make the variable representative of the fac-
tor. The signs of the factor loadings are all positive
and the factor loadings are all statistically significant.
90% of the factor loadings are above 0.80, while the
lowest factor loading is still 0.774, indicating that each
of the four variables is representative of the factor.
Not surprisingly, the factor loadings exhibit the same
overall pattern as the communalities with respect to
the sample as a whole, the sample with North Amer-
ican companies, and the sample consisting of com-
panies from other countries. Furthermore, the factor
loadings reveal the same pattern as the communalities
for the variables patent citations and new products in
the pharmaceutical industry and for the variable new
products in the aerospace and defense industry.
Table 5 and Appendix E also give the total vari-
ance explained by each factor. For the sample as a
whole nearly 85% of the total variance is explained
by one component, that we label as innovative per-
formance in the broad sense based on its appropri-
ateness for representing the underlying dimension of
this particular factor. In the computer and office ma-
chinery sector more than 90% of the total variance
is explained by this component. The pharmaceutical
industry has the lowest percentage explained by the
component, namely 73.23%. The difference of 19.5%
between the average of both the computer and of-
fice machinery sector and the pharmaceutical indus-
try is mainly based on the lower factor loadings for
patent citations and new products in the pharmaceuti-
cal industry. Results for companies from North Amer-
ica and from other countries are almost identical (see
Appendix E).
7. Discussion and conclusions
Our study covers a large sample of nearly 1200
companies found in four high-tech industries. About
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70% of these companies are registered in the USA and
Canada, most of the others are from Europe, Japan,
South Korea and some south east Asian newly indus-
trialized countries.
Our findings regarding the different indicators of
innovative performance in this sample are rather
unambiguous, leaving very little space for ‘subtle’
re-interpretations of the pros and cons of the indi-
vidual indicators. Also, using different time lags or
no time lag at all does not affect the outcome of the
analysis. Hence, we can present a set of clear-cut con-
clusions regarding the possible advantage of multiple
indicators for measuring innovative performance in
high-tech industries.
First, our research suggests that there is no ma-
jor systematic disparity amongst R&D inputs, patent
counts, patent citations and new product announce-
ments (research question 1). A systematic disparity
was found for neither the sample as a whole, nor for
individual sectors, or when taking the international
distribution into account.
Second, the statistical communality of the four indi-
cators of innovative performance is high for the sample
as a whole and for all but one sub-sample (aerospace
and defense outside North America). This indicates
that a composite construct based on these indicators
catches a latent variable ‘innovative performance’ that
measures the performance of companies in high-tech
industries (research question 2). The latent variable in-
novative performance measures the overall, broad in-
terpretation of innovative performance of companies
in terms of their research input, the size of their in-
ventive activities, the quality of their inventive output
and their level of new product introduction (see also
Mohnen and Dagenais, 2002; Mairesse and Mohnen,
2002).
Third, the results of the analysis, however, also
indicate that the overlap between each of these four
indicators is that great (similar to Fig. 1B) that in
high-tech sectors any of these four indicators could
be taken as a measure of innovative performance in
the broad sense (research question 3). Certainly in the
electronics industry at large, with sub-sectors such as
computers, office machinery and electronics and com-
munications, and also in the aerospace and defense
sector, each indicator appears to capture the innova-
tive performance of companies. Although the results
of our statistical analysis certainly do not dictate that
a single indicator approach is invalid for the phar-
maceutical industry, a composite construct that over-
arches all stages of the innovation process could be
used for the measurement of innovative performance
of companies in this particular sector. The factor load-
ings in the analysis of this sector specify a slightly
higher degree of multidimensionality where R&D
inputs and patent counts represent somewhat differ-
ent aspects of innovative performance than patent
citations and new products (see also Trajtenberg,
1990).
Finally, our findings do not imply that there is
no need for additional, context-informed analyses.
Future research could consider a number of topics
relevant for understanding the measurement of in-
novative performance. An obvious item for further
research is to investigate the usefulness of the current
indicators in other industries than these high-tech
sectors. We expect that in a number of industries
with little R&D, indicators based on patents and
new products could still be used although the actual
distribution for these measures might be different.
As part of the continuous effort to build better the-
ories and improved models to understand innovative
performance, it is appealing to focus on the effect
that the strategic behaviour of companies has on
their innovative performance, explaining how this
might influence the different measurements of in-
novative performance. Also, the inclusion of other
indicators might be useful for analysing high-tech
industries, although it appears as if the current
line-up of measures is quite exhaustive. Further-
more, it should be clear that the measurement of
innovative performance in non-manufacturing sec-
tors is in need of a rather different set of indicators.
Obviously, future research should consider some
alternative measures of innovation that are more ap-
propriate in the context of a wide range of service
industries.
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Appendix A. Distribution of companies in the sample, numbers and % distribution for sectors and regions
Industry North America Others Total
Aerospace and defense 38; 4.55%, 64.41% 21; 5.87%, 35.59% 59; 4.94%, 100%
Computers and office machinery 227; 27.15%, 81.07% 53; 14.81%, 18.93% 280; 23.45%, 100%
Pharmaceuticals 152; 18.18%, 62.30% 92; 25.70%, 37.70% 244; 20.44%, 100%
Electronics and communications 419; 50.12%, 68.58% 192; 53.62%, 31.42% 611; 51.17%, 100%
Total 836; 100%, 70.02% 358; 100%, 29.98% 1194; 100%, 100%
Appendix B. Correlations
Variables Total Aerospace
and
defensea
Computers
and office
machinery
Pharmaceuticals Electronics and
communications
North America
Patents and patent citations 0.951 0.793 0.985 0.792 0.897
Patents and R&D expenditures 0.822 0.902 0.921 0.833 0.898
Patents and new products 0.769 0.482 0.786 0.554 0.752
Patent citations and R&D
expenditures
0.778 0.879 0.905 0.562 0.870
Patent citations and new products 0.782 0.770 0.777 0.386 0.811
R&D expenditures and new products 0.796 0.659 0.925 0.864 0.828
Others
Patents and patent citations 0.964 0.859 0.987 0.827 0.968
Patents and R&D expenditures 0.764 −0.30 0.980 0.592 0.787
Patents and new products 0.903 0.122 0.940 0.625 0.907
Patent citations and R&D
expenditures
0.713 −0.23 0.942 0.536 0.747
Patent citations and new products 0.882 0.154 0.938 0.394 0.889
R&D expenditures and new products 0.775 0.940 0.933 0.771 0.791
a Correlation matrix is not positive definite.
Appendix C. Results for the KMO and the MSA measures
Variables Total Aerospace and
defense
Computers and
office machinery
Pharmaceuticals Electronics and
communications
KMO measure 0.762 0.721 0.651 0.695 0.804
MSA measure
R&D expenditures 0.809 0.758 0.652 0.702 0.858
Patent counts 0.703 0.666 0.613 0.705 0.754
Patent citations 0.703 0.788 0.679 0.671 0.750
New products 0.885 0.657 0.665 0.694 0.884
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Appendix D. Communalities for North America and others
Variables Total Aerospace and
defense
Computers and
office machinery
Pharmaceuticals Electronics and
communications
North America
R&D expenditures 0.834 0.921 0.963 0.897 0.917
Patent counts 0.913 0.790 0.936 0.850 0.894
Patent citations 0.897 0.915 0.924 0.611 0.909
New products 0.807 0.633 0.829 0.656 0.810
Others
R&D expenditures 0.743 a 0.963 0.729 0.771
Patent counts 0.946 a 0.989 0.812 0.949
Patent citations 0.910 a 0.969 0.661 0.921
New products 0.907 a 0.940 0.675 0.909
a The correlation and covariance matrix are not positive definite.
Appendix E. Results of the initial unrotated factor analysis
Variables Total Aerospace and
defense
Computers and
office machinery
Pharmaceuticals Electronics and
communications
North America, component 1
R&D expenditures 0.913 0.959 0.982 0.947 0.958
Patent counts 0.956 0.889 0.968 0.922 0.945
Patent citations 0.947 0.957 0.961 0.782 0.953
New products 0.898 0.796 0.911 0.810 0.900
Total Eigenvalue 3.451 3.259 3.653 3.014 3.530
% variance explained 86.28 81.47 91.32 75.35 88.25
Others, component 1
R&D expenditures 0.862 a 0.981 0.854 0.878
Patent counts 0.973 a 0.994 0.901 0.974
Patent citations 0.954 a 0.984 0.813 0.960
New products 0.952 a 0.970 0.822 0.954
Total Eigenvalue 3.506 a 3.861 2.877 3.550
% variance explained 87.66 a 96.51 71.92 88.75
a The correlation and covariance matrix are not positive definite.
Appendix F. Ratios for the different indicators in the sample as a whole and for sub-samples
Industry Patent counts/R&D
expenditures
Patent citations/R&D
expenditures
New products/R&D
expenditures
New products/patent
counts
Aerospace and defense 0.062 0.251 0.012 0.192
Computers and office machinery 0.327 1.759 0.126 0.385
Pharmaceuticals 0.086 0.257 0.026 0.304
Electronics and communications 0.258 1.326 0.060 0.233
Total 0.216 1.072 0.062 0.287
Note: R&D expenditures are in millions of US$.
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